Featured Stories
Seeking Safer Treatments for Hodgkin’s Lymphoma, Dr. Mitchell Cairo to Lead New Clinical Trial
The Clinical Trial Explores the Use of Immunotherapy to Treat the Disease with Fewer Long-term Complications
Nationally renowned pediatric oncologist Mitchell Cairo, M.D., professor of pediatrics, medicine, cell biology and anatomy and of pathology, microbiology, and immunology and vice chair of the Department of Pediatrics, will lead a new clinical trial to advance safer, more precise treatments for Hodgkin’s lymphoma—particularly for children, adolescents, and young adults. The clinical trial is funded in part by a prestigious Empire Clinical Research Investigator Program grant from New York State awarded to Westchester Medical Center (WMC), where Dr. Cairo is chief of pediatric hematology, oncology, and stem cell transplantation; director of Children and Adolescent Cancer and Blood Diseases Center; and director of the WMC Cancer Center.
